Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
Antibodies against coronavirus spike protein potently protect against infection and disease, but whether such protection can be extended to variant coronaviruses is unclear. This is exemplified by a set of iconic and well-characterized monoclonal antibodies developed after the 2003 SARS outbreak, in...
Main Authors: | Romain Rouet, Ohan Mazigi, Gregory J. Walker, David B. Langley, Meghna Sobti, Peter Schofield, Helen Lenthall, Jennifer Jackson, Stephanie Ubiparipovic, Jake Y. Henry, Arunasingam Abayasingam, Deborah Burnett, Anthony Kelleher, Robert Brink, Rowena A. Bull, Stuart Turville, Alastair G. Stewart, Christopher C. Goodnow, William D. Rawlinson, Daniel Christ |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2021.1922134 |
Similar Items
-
Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
by: Chiao-Hsuan Chao, et al.
Published: (2022-11-01) -
Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
by: Lok Bahadur Shrestha, et al.
Published: (2021-09-01) -
Neutralizing and enhancing antibodies against SARS-CoV-2
by: Yafei Liu, et al.
Published: (2022-12-01) -
SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants
by: John Kubale, et al.
Published: (2022-10-01) -
Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display
by: Shiho Tanaka, et al.
Published: (2022-02-01)